Skip to content
Screener

PP&E (Net) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$10.76B+11.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.46B
SIGA Technologies logo
SIGA TechnologiesSIGA
$1.53M+45.9%
AMP
Amphastar PharmaceuticalsAMPH
$316.06M+1.9%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$456.88M+3.8%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$123.71M

Segments

By geography

See full
United States$238M
Canada$34.5M

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$248.16M-47.4%
Enterprise value$695.46M-19.5%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets25.425.8
Assets held-for-sale6.1
Total current assets666.0662.5
Property, plant and equipment, net178.0205.4
Intangible assets, net261.8436.5
Other assets11.014.2
Total assets$1,116.8$1,318.6
LIABILITIES AND STOCKHOLDERS' EQUITY

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Emergent Biosolutions's PP&E (net)?
Emergent Biosolutions (EBS) reported PP&E (net) of $178M in Q2 2026.
How has Emergent Biosolutions's PP&E (net) changed year-over-year?
Emergent Biosolutions's PP&E (net) decreased by 17.6% year-over-year, from $216.1M to $178M.
What is the long-term trend for Emergent Biosolutions's PP&E (net)?
Over 5 years (2020 to 2025), Emergent Biosolutions's PP&E (net) has grown at a -20.4% compound annual growth rate (CAGR), from $644.1M to $205.4M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Emergent Biosolutions's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude